Pharmaceuticals

Global Sartans Market Valuation and Growth Prospects: $26.07 Billion by 2029

December 4, 2025 by Marketing Posting

Uncover key drivers, emerging technologies, and competitive movements shaping the sartans market from 2025–2034 with trusted insights from The Business Research Company

What Are The Future Growth Projections For The Sartans Market Size?

The sartans market size has demonstrated consistent growth in recent years. Projections indicate it will expand from $21.36 billion in 2024 to $22.18 billion in 2025, achieving a compound annual growth rate (CAGR) of 3.8%. The historic period’s growth is attributable to the increasing prevalence of sedentary lifestyles, a higher incidence of obesity, rising awareness concerning cardiovascular diseases, increased healthcare expenditure, and a growing demand for generic antihypertensive drugs.

The sartans market size is anticipated to experience consistent expansion in the coming years. It is projected to achieve a valuation of $26.07 billion by 2029, demonstrating a compound annual growth rate (CAGR) of 4.1%. This growth during the forecast period can be attributed to an intensified focus on combination therapies, increased investments in pharmaceutical research and development, rising demand within emerging markets, the expansion of healthcare infrastructure, and the growing prevalence of lifestyle-related disorders. Key trends for the forecast period encompass advancements in drug delivery technologies, sophisticated manufacturing processes for APIs, the development of fixed-dose combination drugs, innovation in personalized hypertension treatment, and the creation of novel sartan derivatives.

Access A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=24393&type=smp

What Core Market Drivers Are Expanding The Sartans Industry?

The increasing occurrence of hypertension is anticipated to fuel the expansion of the sartans market in the future. Hypertension describes a state characterized by consistently elevated blood pressure, which significantly heightens the risk of developing heart disease, stroke, and other serious health issues. The growing prevalence of this condition is often associated with diets high in salt and processed foods, contributing to fluid retention and greater strain on the heart. Sartans are effective in treating hypertension by impeding angiotensin II, a hormone responsible for constricting blood vessels. This action facilitates the relaxation and widening of these vessels, thereby reducing blood pressure and alleviating the heart’s burden. As an illustration, in January 2024, data from the American Heart Association, a US-based nonprofit organization, indicated that 131,454 deaths were primarily attributed to high blood pressure in 2022, marking an increase from 124,508 deaths recorded in 2021. Consequently, the escalating incidence of hypertension is a primary factor propelling the growth of the sartans market.

What Segment Insights Are Highlighted In The Sartans Market Report?

The sartans market covered in this report is segmented –

1) By Product Type: Valsartan, Telmisartan, Losartan, Irbesartan, Azilsartan, Olmesartan

2) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Other Distribution Channels

3) By Application: Hypertension, Cardiovascular Diseases, Kidney Diseases, Other Applications

4) By End-User: Hospitals, Diagnostic Laboratories, Other End-Users

Which Notable Trends Are Transforming The Sartans Market Outlook?

Companies operating in the sartans market are concentrating on developing advanced products, such as tablet-form sartans, to boost treatment efficacy and patient adherence. These tablet-form sartans are oral medications that incorporate sartan drugs, which work by blocking the effects of angiotensin II, thereby promoting blood vessel relaxation and reducing blood pressure. For instance, in July 2024, Zydus Lifesciences, an India-based pharmaceutical company, received US Food and Drug Administration (FDA) approval for Valsartan Tablets USP (40 mg, 80 mg). These tablets are marketed under the brand name Diovan. They are prescribed to treat hypertension and heart failure, improve survival post-heart-attack in adults, and are also suitable for pediatric patients aged one year and older.

Which Firms Are Driving Innovation Within The Sartans Market?

Major companies operating in the sartans market are Viatris Inc., Teva Pharmaceutical Industries Ltd., Intas Pharmaceuticals Ltd., Sun Pharmaceutical Industries Ltd., Apotex Inc., Aurobindo Pharma Ltd., Dr. Reddy’s Laboratories Ltd., Cipla Ltd., Cadila Pharmaceuticals Ltd., Lupin Ltd., Zydus Lifesciences Ltd., Torrent Pharmaceuticals Ltd., Alembic Pharmaceuticals Ltd., Vasudha Pharma Chem Ltd., Unichem Laboratories Ltd., Global Pharma Tek, Manus Aktteva Biopharma LLP, Emcure Pharmaceuticals Ltd., Wellona Pharma, JPM Pharma & Chemicals Pvt. Ltd.

Download The Full Report Here:

https://www.thebusinessresearchcompany.com/report/sartans-global-market-report

What Regional Trends Are Shaping Growth In The Sartans Market?

North America was the largest region in the sartans market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the sartans market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Get A Report Customized For You Here:

https://www.thebusinessresearchcompany.com/customise?id=24393&type=smp

Browse Through More Reports Similar to the Global Sartans Market 2025, By The Business Research Company

Central Nervous System Drug Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/central-nervous-system-drug-global-market-report

Cervical Cancer Drugs Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/cervical-cancer-drugs-global-market-report

Colorectal Cancer Drugs Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/colorectal-cancer-drugs-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795